{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Milestone Pharmaceuticals Inc."},"Symbol":{"label":"Symbol","value":"MIST"},"Address":{"label":"Address","value":"1111 DR. FREDERIK-PHILIPS BOULEVARD,SUITE 420, MONTREAL, Quebec, H4M 2X6, Canada"},"Phone":{"label":"Phone","value":"+1 514 336-0444"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications."},"CompanyUrl":{"label":"Company Url","value":"https://www.milestonepharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anita Holz","title":"Vice President & Head-Medical Affairs"},{"name":"David B. Bharucha","title":"Chief Medical Officer"},{"name":"Debbie K. Everidge","title":"Vice President-Information Technology"},{"name":"Jeff Nelson","title":"Chief Operating Officer"},{"name":"Joseph G. Oliveto","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}